E
Profound Medical Corp. PRN.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -46.35% -101.05% 43.04% -35.34% -5.07%
Total Depreciation and Amortization -13.50% -23.11% -4.93% -4.70% -6.40%
Total Amortization of Deferred Charges -- -- -402.22% -- --
Total Other Non-Cash Items 40.47% 281.63% -177.53% -10.21% -5.13%
Change in Net Operating Assets -70.72% 586.81% -90.91% 677.23% -136.56%
Cash from Operations -65.93% -46.81% 11.33% -2.32% -37.32%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid 100.00% 44.55% 21.35% -10.10% 3.05%
Issuance of Common Stock -- -- -- -100.00% -100.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- 100.00%
Cash from Financing 100.00% -100.81% 5,461.35% -10.28% -102.95%
Foreign Exchange rate Adjustments 2,565.96% 104.23% -3,186.11% 125.81% 70.94%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -32.54% -130.51% 499.50% 2.04% -147.44%